1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Global Autoimmune Disease Therapeutics Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)

Global Autoimmune Disease Therapeutics Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)

  • February 2021
  • 82 pages
  • ID: 6025440
  • Format: PDF
  • Daedal Research


Table of Contents

Search Inside

Scope of the Report
The report titled “Global Autoimmune Disease Therapeutics Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)”, provides an in depth analysis of the global autoimmune disease therapeutics market by value, by drug class, by indication, by region, etc. The report provides a regional analysis of the autoimmune disease therapeutics market, including the following regions: North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. The report also provides a detailed analysis of the COVID-19 impact on the autoimmune disease therapeutics market.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global autoimmune disease therapeutics market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The global autoimmune disease therapeutics market is fragmented with many major market players operating worldwide. The key players of the autoimmune disease therapeutics market are Roche Holding AG, Pfizer Inc., Johnson & Johnson, and Abbott Laboratories are also profiled with their financial information and respective business strategies.

Country Coverage
North America
Asia Pacific
Middle East & Africa
Latin America

Company Coverage
Roche Holding AG
Pfizer Inc.
Johnson & Johnson
Abbott Laboratories

Executive Summary
An autoimmune disease is a condition in which the body’s immune system attacks and destroys healthy cells and tissues in the body by mistake. In other words, autoimmune disease arises when the immune system fails to distinguish between the body’s own cells and foreign cells. These diseases can affect any part of the body. Autoimmune disease therapeutics is a form of treatment to calm the overactive immune response, to limit tissue damage, and to reduce pain and inflammation. Treatment can also help in relieving symptoms like pain, swelling, and skin rashes.

There are a lot of therapeutic alternatives available, but no option has a perfect safety profile. Infact, while some treatments have been effective in treating certain autoimmune disorders, no treatment is effective for all autoimmune diseases.

The autoimmune disease therapeutics market can be segmented on the basis of drug class (Immunosuppressant’s, Anti-inflammatory Drug, Interferons, NSAIDs, Antihyperglycemics, and Others); indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes, Psoriasis, and Others); and distribution channel (Hospital & Clinics, Pharmacies, Drug Stores, Online Stores, and Others).

The global autoimmune disease therapeutics market has increased significantly during the years 2018-2020 and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The autoimmune disease therapeutics market is expected to increase due to rapid urbanization, escalating healthcare spending, rising prevalence of autoimmune diseases, favorable government initiatives, etc. Yet the market faces some challenges such as high cost involved, lack of approved treatment for IPF (Idiopathic Pulmonary Fibrosis), etc.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Hidradenitis Suppurativa (Dermatology) - Drugs in Development, 2021

  • $ 2000
  • March 2021
  • 279 pages

Hidradenitis Suppurativa (Dermatology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hidradenitis Suppurativa - Drugs in Development, 2021, provides ...

  • World
  • South Africa
  • Autoimmune Disease
  • Industry analysis
  • Pharmaceutical Registrations
  • Drug Approval


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on